Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Longitudinal analysis of patient-reported outcomes and cosmesis in a randomized trial of conventionally fractionated versus hypofractionated whole-breast irradiation.

Swanick CW, Lei X, Shaitelman SF, Schlembach PJ, Bloom ES, Fingeret MC, Strom EA, Tereffe W, Woodward WA, Stauder MC, Dvorak T, Thompson AM, Buchholz TA, Smith BD.

Cancer. 2016 Sep 15;122(18):2886-94. doi: 10.1002/cncr.30121.

PMID:
27305037
2.

Unintended irradiation of internal mammary chain - Is that enough?

Sapienza LG, Chen MJ, Gomes MJ, Mansur DB.

Rep Pract Oncol Radiother. 2016 Jan-Feb;21(1):25-30. doi: 10.1016/j.rpor.2015.07.006.

3.

Radiotherapy of the Lymphatic Pathways in Early Breast Cancer.

Sautter-Bihl ML, Sedlmayer F.

Breast Care (Basel). 2015 Aug;10(4):254-8. doi: 10.1159/000438662. Review.

4.

Regional Nodal Irradiation in Early-Stage Breast Cancer.

Whelan TJ, Olivotto IA, Parulekar WR, Ackerman I, Chua BH, Nabid A, Vallis KA, White JR, Rousseau P, Fortin A, Pierce LJ, Manchul L, Chafe S, Nolan MC, Craighead P, Bowen J, McCready DR, Pritchard KI, Gelmon K, Murray Y, Chapman JA, Chen BE, Levine MN; MA.20 Study Investigators..

N Engl J Med. 2015 Jul 23;373(4):307-16. doi: 10.1056/NEJMoa1415340.

5.

Postmastectomy radiation therapy for T3N0: a SEER analysis.

Johnson ME, Handorf EA, Martin JM, Hayes SB.

Cancer. 2014 Nov 15;120(22):3569-74. doi: 10.1002/cncr.28865.

6.

Toxicity and cosmetic outcome of hypofractionated whole-breast radiotherapy: predictive clinical and dosimetric factors.

Ciammella P, Podgornii A, Galeandro M, Micera R, Ramundo D, Palmieri T, Cagni E, Iotti C.

Radiat Oncol. 2014 Apr 24;9:97. doi: 10.1186/1748-717X-9-97.

7.

The impact of radiation therapy on the risk of lymphedema after treatment for breast cancer: a prospective cohort study.

Warren LE, Miller CL, Horick N, Skolny MN, Jammallo LS, Sadek BT, Shenouda MN, O'Toole JA, MacDonald SM, Specht MC, Taghian AG.

Int J Radiat Oncol Biol Phys. 2014 Mar 1;88(3):565-71. doi: 10.1016/j.ijrobp.2013.11.232.

8.

Postmastectomy radiation therapy: an overview for the practicing surgeon.

Jagsi R.

ISRN Surg. 2013 Sep 11;2013:212979. doi: 10.1155/2013/212979. Review.

9.

Breast reconstruction and post-mastectomy radiation practice.

Chen SA, Hiley C, Nickleach D, Petsuksiri J, Andic F, Riesterer O, Switchenko JM, Torres MA.

Radiat Oncol. 2013 Mar 2;8:45. doi: 10.1186/1748-717X-8-45.

10.

Patterns and risk factors for locoregional failures after mastectomy for breast cancer: an International Breast Cancer Study Group report.

Karlsson P, Cole BF, Chua BH, Price KN, Lindtner J, Collins JP, Kovács A, Thürlimann B, Crivellari D, Castiglione-Gertsch M, Forbes JF, Gelber RD, Goldhirsch A, Gruber G; International Breast Cancer Study Group..

Ann Oncol. 2012 Nov;23(11):2852-8. doi: 10.1093/annonc/mds118.

11.

Five-year local control in a phase II study of hypofractionated intensity modulated radiation therapy with an incorporated boost for early stage breast cancer.

Freedman GM, Anderson PR, Bleicher RJ, Litwin S, Li T, Swaby RF, Ma CM, Li J, Sigurdson ER, Watkins-Bruner D, Morrow M, Goldstein LJ.

Int J Radiat Oncol Biol Phys. 2012 Nov 15;84(4):888-93. doi: 10.1016/j.ijrobp.2012.01.091.

12.

Challenges in ductal carcinoma in situ risk communication and decision-making: report from an American Cancer Society and National Cancer Institute workshop.

Partridge AH, Elmore JG, Saslow D, McCaskill-Stevens W, Schnitt SJ.

CA Cancer J Clin. 2012 May-Jun;62(3):203-10. doi: 10.3322/caac.21140.

13.

Comparative effectiveness of ductal carcinoma in situ management and the roles of margins and surgeons.

Dick AW, Sorbero MS, Ahrendt GM, Hayman JA, Gold HT, Schiffhauer L, Stark A, Griggs JJ.

J Natl Cancer Inst. 2011 Jan 19;103(2):92-104. doi: 10.1093/jnci/djq499.

14.

Impact of the radiation boost on outcomes after breast-conserving surgery and radiation.

Murphy C, Anderson PR, Li T, Bleicher RJ, Sigurdson ER, Goldstein LJ, Swaby R, Denlinger C, Dushkin H, Nicolaou N, Freedman GM.

Int J Radiat Oncol Biol Phys. 2011 Sep 1;81(1):69-76. doi: 10.1016/j.ijrobp.2010.04.067.

15.

Postmastectomy radiotherapy for breast cancer: patterns, correlates, communication, and insights into the decision process.

Jagsi R, Abrahamse P, Morrow M, Griggs JJ, Schwartz K, Katz SJ.

Cancer. 2009 Mar 15;115(6):1185-93. doi: 10.1002/cncr.24164.

16.

Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer.

Gruber G, Cole BF, Castiglione-Gertsch M, Holmberg SB, Lindtner J, Golouh R, Collins J, Crivellari D, Thürlimann B, Simoncini E, Fey MF, Gelber RD, Coates AS, Price KN, Goldhirsch A, Viale G, Gusterson BA; International Breast Cancer Study Group..

Ann Oncol. 2008 Aug;19(8):1393-401. doi: 10.1093/annonc/mdn123.

17.

Current perceptions regarding surgical margin status after breast-conserving therapy: results of a survey.

Taghian A, Mohiuddin M, Jagsi R, Goldberg S, Ceilley E, Powell S.

Ann Surg. 2005 Apr;241(4):629-39.

Supplemental Content

Support Center